Skip to main
PATH

UiPath (PATH) Stock Forecast & Price Target

UiPath (PATH) Analyst Ratings

Based on 15 analyst ratings
Hold
Strong Buy 13%
Buy 0%
Hold 80%
Sell 7%
Strong Sell 0%

Bulls say

UiPath Inc. reported total revenue of $481.1 million, reflecting a year-over-year growth of approximately 14%, which surpassed initial estimates, indicating strong performance in the enterprise automation market. The company's remaining performance obligations (RPO) reached $1.475 billion, a 19% increase year-over-year, while the annualized renewal run-rate (ARR) of $1.853 billion also exhibited a growth of around 11% year-over-year. Notably, the number of customers generating over $100,000 in ARR increased by 12%, underscoring UiPath's expanding client base and solidifying its position in the automation sector.

Bears say

UiPath's financial outlook is negatively impacted by a broad-based selloff across the software industry, leading to a compression of multiples and a reduction in price targets. The company's inorganic growth from the acquisition of WorkFusion, alongside unfavorable foreign exchange effects and limited guidance for operating margin expansion, have contributed to a decline in shares. Additionally, the risk of declining revenue growth and margins, compounded by increasing competition and the potential delay in achieving GAAP breakeven, suggests further deterioration in UiPath's financial performance and stock valuation.

UiPath (PATH) has been analyzed by 15 analysts, with a consensus rating of Hold. 13% of analysts recommend a Strong Buy, 0% recommend Buy, 80% suggest Holding, 7% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UiPath and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UiPath (PATH) Forecast

Analysts have given UiPath (PATH) a Hold based on their latest research and market trends.

According to 15 analysts, UiPath (PATH) has a Hold consensus rating as of Mar 31, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UiPath (PATH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.